According to Elanco's latest financial reports the company's current revenue (TTM) is $4.54 B. In 2021 the company made a revenue of $4.76 B an increase over the years 2020 revenue that were of $3.27 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2022 (TTM) | $4.54 B | -4.66% |
2021 | $4.76 B | 45.57% |
2020 | $3.27 B | 6.59% |
2019 | $3.07 B | 0.14% |
2018 | $3.06 B |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
![]() OPKO Health
OPK | $1.22 B | -73.14% | ๐บ๐ธ USA |
![]() Onconova Therapeutics ONTX | $0.22 M | -100.00% | ๐บ๐ธ USA |